By |

Profile

CareDx Inc operates as a transplant diagnostics company, which offers pre- and post-transplant continuum. The company focuses on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic surveillance solutions for transplant patients. Its product includes AlloMap, which aids clinicians in identifying heart transplant recipients with stable allograft function and AlloSure, which is a donor-derived cell free DNA test.

Contact Information

Website: www.caredx.com
Email: sking@caredx.com
Main Phone: +1 415 287-2300
Address: 3260 Bayshore Boulevard
State: CA
City / Town: Brisbane
Country: USA
Postal Code: 94005

Issuer Information

Exchange: NSD
CEO: Peter Maag
Employees: 231
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)


Gathering Data... Please wait

Profile

CareDx Inc operates as a transplant diagnostics company, which offers pre- and post-transplant continuum. The company focuses on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic surveillance solutions for transplant patients. Its product includes AlloMap, which aids clinicians in identifying heart transplant recipients with stable allograft function and AlloSure, which is a donor-derived cell free DNA test.

Contact Information

Website: www.caredx.com
Email: sking@caredx.com
Main Phone: +1 415 287-2300
Address: 3260 Bayshore Boulevard
State: CA
City / Town: Brisbane
Country: USA
Postal Code: 94005

Issuer Information

Exchange: NSD
CEO: Peter Maag
Employees: 231
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)
$ 36.90 $ -0.37 (-0.99%)
Last Price 36.90 Change $ -0.37 Change % -0.99 Tick N/A
Bid 36.15 Bid Size 100.00 Ask 41.01 Ask Size 100.00
Open 37.72 High 38.25 Low 36.38 Prev Close 37.27
Last Trade Volume 692,038 52 Wk Hi 39.38 52 Wk Low 7.08
Market Cap 1.5 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 41,728,442.00 EPS (TTM) -1.29 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 7 77
Number of Buys 5 57
Number of Sells 2 20
Net Activity -45791 121033
Last 10 Buys Shares
Gagnon Neil 1,000
Gagnon Neil 1,000
Gagnon Neil 1,000
Gagnon Neil 1,000
Gagnon Neil 1,000
Gagnon Neil 1,000
Gagnon Neil 1,000
Gagnon Neil 1,000
Gagnon Neil 1,000
Gagnon Neil 1,000
Last 10 Sell Shares
Peter Maag 1,000
James P. Yee 1,000
Mitchell J. Nelles 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 17 14 14 17
Low Target Price Estimate 10 10 10 10
Mean Target Price Estimate 13.67 12.67 12.67 14
Standard Deviation 3.51 2.31 2.31 3.61
Date of Most Recent Estimate 06/06/18 05/11/18 05/11/18 06/19/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 3 3 3
Moderate Buy 0 0 0 1
Hold 1 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.67 1 1 1.25